Mini Review
Published on 04 Dec 2025
Rewiring immune evasion in liver metastases: WNT11 as a central node — a mini review
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1666889
- 207 views
Type at least 3 characters
3,120 articles
Review
Published on 03 Dec 2025
Recent progress in serine metabolism reprogramming in tumors and strategies for serine deprivation
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1669565
- 176 views
Editorial
Accepted on 02 Dec 2025
Role of Nanocarriers and Non-coding RNAs in Solid Malignancies
in Molecular and Cellular Oncology
Frontiers in Oncology
Review
Published on 02 Dec 2025
Deciphering molecular pathways driving cancer invasion and metastasis: advances and therapeutic prospects
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1684896
- 464 views
Correction
Published on 02 Dec 2025
Correction: ABLIM1: a novel oncogenic E3 ligase in colorectal cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1753402
- 222 views
Original Research
Accepted on 29 Nov 2025
Quantification of TERT promoter mutations in tumor DNA shed into the oral cavity as a potential biomarker for oral squamous cell carcinoma
in Molecular and Cellular Oncology
Frontiers in Oncology
- 110 views
Original Research
Accepted on 28 Nov 2025
Cetrorelix promotes cell apoptosis via the PI3K–AKT–FOXO1 pathway in epithelial ovarian cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
Original Research
Published on 25 Nov 2025
Integrative modeling of FOXO-mediated autophagy in NSCLC: linking cGAS–STING signaling to IL-6 dynamics
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1689137
- 484 views
Original Research
Published on 24 Nov 2025
BAG3 in human tumors
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1725674
- 476 views
Case Report
Published on 24 Nov 2025
Case Report: Blood single-cell analysis of a IVB high-grade serous ovarian cancer patient presenting a favorable prognosis
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1697863
- 574 views
Original Research
Accepted on 20 Nov 2025
TBX21 correlates with an immunosuppressive tumor microenvironment and Treg/Th17 imbalance in prostate cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
Opinion
Published on 20 Nov 2025
ABLIM1: A novel oncogenic E3 ligase in colorectal cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1718420
- 601 views
Review
Published on 11 Nov 2025
Post-translational modifications of protein and lung cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1667200
- 691 views
Original Research
Published on 06 Nov 2025
PPP2CA knockdown upregulates the expression levels of ferroptosis-related genes TFRC and ACSL4 in colorectal cancer cells by promoting mTOR phosphorylation
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1694932
- 590 views
Brief Research Report
Accepted on 30 Oct 2025
Persistently high prevalence of HPV16 and Rising Prevalence of Non-16/18 HR-HPV Genotypes in Cervical Precancer and Cancer in Latvia in 2016-2024 Shape the Severity of Cervical Disease
in Molecular and Cellular Oncology
Frontiers in Oncology
Original Research
Published on 28 Oct 2025
Temporal dynamics of cisplatin-induced endothelial senescence and its association with cognitive impairment: insights into the medial prefrontal cortex
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1668372
- 856 views